|
HCC patients
|
|
No. of patients
|
188
|
|
Age (median; range), years
|
50; 13–76
|
|
Gender (male/female)
|
159/29 (84.6/15.4)
|
|
HBV infection (no/yes)
|
19/169 (10.1/89.9)
|
|
Alpha-fetoprotein, ng/mL (≤2 5/>25)
|
74/114 (39.4/60.6)
|
|
Child–Pugh class (A/B)
|
175/13 (93.1/6.9)
|
|
Tumor number (single/multiple)
|
144/44 (76.6/23.4)
|
|
Tumor size, cm (≤5/>5)
|
80/108 (42.6/57.4)
|
|
Vascular invasion (absent/present)
|
177/11 (94.1/5.9)
|
|
TNM stage (I/II/III)
|
130/16/39 (69.1/10.1/20.8)
|
|
Histological grade (I/II/III/other)
|
125/63 (66.5/33.5)
|
|
GC patients
|
|
No. of patients
|
138
|
|
Age (median; range), years
|
69; 28–78
|
|
Gender (male/female)
|
100/38 (72.5/27.5)
|
|
Tumor size, cm (≤4/>4)
|
46/92 (33.3/66.7)
|
|
Tumor depth (pT1/pT2/pT3/pT4)
|
3/10/34/91 (2.2/7.2/24.7/65.9)
|
|
Lymph node metastasis (pN0/pN1/pN2/pN3)
|
29/31/27/51 (21.0/22.5/19.5/37.0)
|
|
TNM stage (IA/IB/II/IIIA/IIIB/IIIC)
|
3/6/5/25/32/32/35 (2.2/4.3/3.6/18.1/23.2/23.2/25.4)
|
|
Histological grade (I/II/III/other)
|
3/32/90/11 (2.2/23.2/65.2/8.0)
|
